13
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0247 |
7-Epi-docetaxel
7-Epidocetaxel,7-表多西他赛,4-epi-Docetaxel,7-Epitaxotere |
Others | Others |
7-Epi-10-oxo-docetaxel (7-Epitaxotere) is a impurity of docetaxel. | |||
TQ0142 |
10-Oxo Docetaxel
Docetaxel Impurity 1,10-氧多西他赛 |
Others | Others |
10-Oxo Docetaxel is a Docetaxel intermediate having remarkable antitumor properties. | |||
T19163 |
7-Epi-10-oxo-docetaxel
Docetaxel Impurity 2 |
Others | Others |
7-Epi-10-oxo-docetaxel (Docetaxel Impurity 2) is an impurity of docetaxel detected by HPLC. | |||
T38644 |
Docetaxal
PNU-101383,10-Acetyl docetaxel |
||
Docetaxal, also known as 10-Acetyl docetaxel, is an analog of Docetaxel exhibiting potent anticancer properties. It acts as a microtubule disassembly inhibitor, effectively inhibiting mitosis. | |||
T74418 |
Sudocetaxel
|
||
Sudocetaxel 是一种可以用于pH 敏感的多西紫杉醇释放的微管解聚抑制剂。 | |||
T11122 |
DUPA(OtBu)-OH
(S)-5-叔丁氧基-4-(3-((S)-1,5-二-叔丁氧基-1,5-二氧代-2-戊基)脲啶)-5-氧代戊酸 |
Others | Others |
DUPA(OtBu)-OH 是DUPA 前体。其中 DUPA 是传递 Docetaxel (DTX) 的靶向基序,可用于表达前列腺特异性膜抗原的前列腺肿瘤的研究。 | |||
T60372 |
ALDH3A1-IN-1
|
||
ALDH3A1-IN-1 (Compound 18) 是一种有效的ALDH3A1抑制剂,IC50为 1.61 μM。ALDH3A1-IN-1 比 DEAB 更有效地对抗患者来源的原发性前列腺肿瘤上皮细胞,无论是作为单药或与多西紫杉醇联合治疗。 | |||
T15713 |
Larotaxel
XRP9881 |
P-gp | Membrane transporter/Ion channel; Neuroscience |
Larotaxel (XRP9881) 是一种紫杉烷类似物,具有抗癌活性,通过促进微管蛋白装配和稳定微管发挥其细胞毒性作用,并通过细胞凋亡诱导细胞死亡。Larotaxel (XRP9881) 是一种可穿过血脑屏障的化合物,对 Docetaxel 的亲和力比 P-糖蛋白 1 高,可用于研究乳腺癌和膀胱癌。 | |||
T6695 |
Tasquinimod
他喹莫德,ABR-215050 |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Tasquinimod (ABR-215050) 是一种口服抗血管生成剂,有潜在的抗肿瘤活性。它也是 S100A9抑制剂,与 HDAC4Zn2+结合结构域结合的 Kd 值在10到30 nM 之间。 | |||
T15514 |
Hydroxy-PEG10-Boc
|
Others | Others |
Hydroxy-PEG10-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG10-Boc can be conjugated to Paclitaxel or docetaxel [2]. | |||
TP2051 |
CTCE-9908
CTCE 9908 |
||
CXCR4 antagonist; induces mitotic catastrophe in ovarian cancer cells. Displays additive cytotoxic effects when given with taxol. Enhances the efficacy of docetaxel in a mouse model. | |||
T82327 | GEM–IB | ||
GEM–IB是一种由吉西他滨(GEM)-5'-磷酸与伊班膦酸盐(IB)组成的复合物。在小鼠骨肉瘤(OS)模型中,GEM–IB能够作为独立活性分子减轻肿瘤负担,并在与多西紫杉醇(DTX)联合使用时,能进一步保护骨结构并提高生存率。 | |||
T28216 |
NTRC 0066-0
NTRC-0066-0,NTRC-00660,NTRC00660,NTRC0066-0 |
||
NTRC-0066-0 is a a highly potent and selective inhibitor of TTK. NTRC 0066-0 inhibits the phosphorylation of a TTK substrate and induces chromosome missegregation. NTRC 0066-0 inhibits tumor growth in MDA-MB-231 xenografts as a single agent after oral app |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1034 |
Docetaxel
多西他赛,NSC 628503,RP-56976,多烯紫杉醇 |
Apoptosis; Microtubule Associated; Endogenous Metabolite | Apoptosis; Cytoskeletal Signaling; Metabolism |
Docetaxel (RP-56976) 是紫杉醇的半合成类似物,是一种微管解聚抑制剂 (IC50=0.2 μM)。Docetaxel 可以减弱 bcl-2 和 bcl-xL 基因表达的影响,具有诱导凋亡、抗肿瘤活性。 | |||
T0186 |
Docetaxel trihydrate
RP-56976 (Trihydrate),RP56976 (NSC 628503) Trihydrate,多西他赛三水合物 |
Apoptosis; BCL; Microtubule Associated | Apoptosis; Cytoskeletal Signaling |
Docetaxel trihydrate (RP-56976 Trihydrate) 是一种抗肿瘤试剂,抑制微管解聚的IC50值为 0.2 μM。它是紫杉醇的半合成类似物,能减弱 bcl-2 和 bcl-xL 基因表达的影响。它阻滞G2/M 细胞周期,导致细胞凋亡。 | |||
T2543 |
Cabazitaxel
XRP6258,卡巴他塞,RPR-116258A,TXD 258,taxoid XRP6258 |
Microtubule Associated; Autophagy | Autophagy; Cytoskeletal Signaling |
Cabazitaxel (taxoid XRP6258) 是一种紫杉烷类的抗肿瘤剂,可用于治疗多西他赛失败后的去势抵抗性转移性前列腺癌。 |